Quick Search:       Advanced Search
Effect of menopausal status on long-term outcome of women undergoing drug-eluting stent implantation
Received:August 14, 2020  Revised:October 07, 2020  Click here to download the full text
Citation of this paper:WANG Xiang-fei,DORJE Ta-shi,WANG Qi-bing,FAN Bing,QIAN Ju-ying,GE Lei,MA Jian-ying,ZHANG Feng,YAO Kang,GE Jun-bo.Effect of menopausal status on long-term outcome of women undergoing drug-eluting stent implantation[J].Chinese Journal of Clinical Medicine,2021,28(2):258-261
Hits: 934
Download times: 396
Author NameAffiliationE-mail
WANG Xiang-fei Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
DORJE Ta-shi Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
WANG Qi-bing Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
FAN Bing Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
QIAN Ju-ying Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
GE Lei Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
MA Jian-ying Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
ZHANG Feng Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
YAO Kang Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
GE Jun-bo Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China ge.junbo@zs-hospital.sh.cn 
Abstract:Objective: To explore the relationship between menopausal status and long-term outcome of patients with coronary heart disease (CHD) after drug-eluting stent implantation. Methods: The data of 143 patients with CHD who were less than 55 years old and implanted with drug-eluting stents in Zhongshan Hospital, Fudan University from January 2008 to December 2014 were retrospectively analyzed. According to the status of menopause, patients were divided into premenopausal women group (n=50) and postmenopausal women group (n=93). Results: Compared with the postmenopausal women, the premenopausal women were younger, and had a higher rate of positive family history of CHD. The median follow-up time was 823 days. The incidence of major cardiac adverse events (MACEs) was not significantly different between the two groups. The event-free survival rate was not significantly different between the two groups. Cox regression analysis showed that the independent predictors of MACEs included the multi-vessel disease and lower estimated GFR other than menopausal status. Conclusions: In women with CHD, the premenopausal status might not be a influence factor for MACEs.
keywords:coronary artery disease  percutaneous coronary intervention  drug-eluting stent  female  menopause
HTML  View Full Text  View/Add Comment  Download reader